B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
Jang‐June Park, Ryusuke Omiya, Yumiko Matsumura et al. · Blood · 2010
T-cell tolerance is the central program that prevents harmful immune responses against self-antigens, in which inhibitory PD-1 signal given by B7-H1 interaction plays an important role. Recent studies demonstrated that B7-H1 binds CD80 besides PD-1, and B7-H1/CD80 interaction also delivers inhibitory signals in T cells. However, a role of B7-H1/CD80 signals in regulation of T-cell tolerance has yet to be explored. We report here that attenuation of B7-H1/CD80 signals by treatment with anti-B7-H1 monoclonal antibody, which specifically blocks B7-H1/CD80 but not B7-H1/PD-1, enhanced T-cell expansion and prevented T-cell anergy induction. In addition, B7-H1/CD80 blockade restored Ag responsiveness in the previously anergized T cells. Experiments using B7-H1 or CD80-deficient T cells indicated that an inhibitory signal through CD80, but not B7-H1, on T cells is responsible in part for these effects. Consistently, CD80 expression was detected on anergic T cells and further up-regulated when they were re-exposed to the antigen (Ag). Finally, blockade of B7-H1/CD80 interaction prevented oral tolerance induction and restored T-cell responsiveness to Ag previously tolerized by oral administration. Taken together, our findings demonstrate that the B7-H1/CD80 pathway is a crucial regulator in the induction and maintenance of T-cell tolerance.
Cited by 330 works. doi:10.1182/blood-2010-01-265975 Open-access PDF
Authors
- Jang‐June Park
- Ryusuke Omiya
- Yumiko Matsumura
- Yukimi Sakoda
- Atsuo Kuramasu
- Mathew M. Augustine
- Sheng Yao
- Fumihiko Tsushima
- Hidehiko Narazaki
- Sudarshan Anand
- Scott Eric Strome
- Lieping Chen
- Koji Tamada
References
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
- Restoring function in exhausted CD8 T cells during chronic viral infection
- Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses
- Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity
- Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity
- CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
- Tissue expression of PD-L1 mediates peripheral T cell tolerance
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine